Perrigo sees 2% sales growth in 2019

Ahead of its presentation at JPMorgan’s Healthcare Conference, Perrigo (NYSE:PRGO) announces preliminary results for Q4 and 2019.

Q4: Consumer Self-Help Americas: +15%; Consumer Self-Help International: -8%; Rx segment: +3%.

Unaudited full-year sales were $4.8B (+2%), global Consumer sales up 2% to $3.9B, Consumer Self-Care Americas up ~3% to $2.5B, Consumer Self-Help International down 1% to ~$1.4B, Rx segment up 5% to ~$970M.

Final results for Q4 and 2019 will be released in late February.

Shares up 4% premarket.

https://seekingalpha.com/news/3531678-perrigo-sees-2-sales-growth-in-2019